Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02924116 · ClinicalTrials.gov registry record · NA

Bioboosti Device for Insomnia Treatment

A NA study of Insomnia, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT02924116 is a NA study of Insomnia that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02924116, a NA study of Insomnia, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the effects of the Bioboosti device on sleep for patients who have been diagnosed with insomnia.

Conditions Studied

Insomnia

Interventions

  • DEVICE Bioboosti

Study Locations (2)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Brigham and Women's Faulkner Hospital - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-09
Est. Completion 2025-04
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02924116

The ClinicalTrials.gov registry entry for NCT02924116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (88% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Bioboosti is the first listed.

NCT02924116 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02924116 about?

NCT02924116 is a clinical study titled "Bioboosti Device for Insomnia Treatment". The purpose of this study is to determine the effects of the Bioboosti device on sleep for patients who have been diagnosed with insomnia.

What is the current status of trial NCT02924116?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2025-04.

What conditions does trial NCT02924116 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT02924116?

The interventions under investigation include: Bioboosti (DEVICE).

Who is sponsoring clinical trial NCT02924116?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02924116 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insomnia

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.